Evidence in favour
- Participation spans 15 named insiders rather than one filing source.
Company insider dossier
HealthEquity Inc insider intelligence
HQY filings assessed for conviction, transaction quality, insider breadth, clustering, freshness, and price confirmation.
32/100
Concentrated distribution
86/100 confidence- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Health Information Services
- Latest evidence
- 25 Aug 2026
Investment committee read
Concentrated distribution
Priced common-share disposals are concentrated enough to warrant review, but they are not treated as a standalone bearish forecast.
Review exposure and filing contextDecision risks
- Qualifying disposal events outnumber acquisitions, although disposals receive a lower directional weight.
Price confirmation map
Weekly price with common-share events
Acquisitions and disposals are aligned to the nearest completed weekly bar.
Mar 2025Sep 2026
Weekly closeCommon-share acquisitionCommon-share disposal
Market confirmation
Price and trend context
- Latest close
- 96.26 USD
- One-week move
- +0.2%
- Four-week move
- -8.1%
- Fair-value gap
- +10.3%
- Trend signal
- Active
- Relative strength
- -3.7
Directional balance
Controlled event mix
8.3%acquisition
- Acquisition events
- 2
- Disposal events
- 22
- Net value
- -$7.9M
Cadence
Twelve-week filing pressure
Volume shows attention. Controlled events determine direction.
129 Jun
706 Jul
013 Jul
020 Jul
027 Jul
003 Aug
010 Aug
017 Aug
424 Aug
031 Aug
007 Sep
014 Sep
Named participants
Insider conviction by person
WELLBORN, GAYLE FURGURSONDirector612 events
DILLON, ADRIAN TDirector533 events
DILSAVER, EVELYN SDirector500 events
GASSEN, WILLIAMDirector500 events
MCCOWAN, DEBRA CHARLOTTEDirector500 events
NATARAJAN, RAJESHDirector500 events
PARKER, STUART B.Director500 events
SELANDER, ROBERT WDirector500 events
GATHRIGHT, MICHAELChief Customer Officer281 events
CUTLER, SCOTTDirector, President and CEO252 events
LUCANIA, JAMES MEVP & CFO252 events
ROSNER, ELIMELECHEVP, CHIEF TECHNOLOGY OFFICER252 events
Evidence quality
Security and transaction context
Role architecture
Who is participating
Transaction evidence
Auditable HQY filing ledger
Showing 1 to 30 of 44.
DILLON, ADRIAN TDirector
DisposalOptions and derivatives
7632 sharesStock Option (right to buy)
Not reportedContext evidence
DILLON, ADRIAN TDirector
DisposalCommon equity
6300 sharesCommon Stock
$658.2KDirectional evidence
DILLON, ADRIAN TDirector
AcquisitionCommon equity
7632 sharesCommon Stock
$248.0KDirectional evidence
DILLON, ADRIAN TDirector
DisposalCommon equity
1332 sharesCommon Stock
$140.2KDirectional evidence
FIORE, MICHAEL HENRYEVP, CHIEF COMMERCIAL OFFICER
DisposalCommon equity
2354 sharesCommon Stock
$223.6KDirectional evidence
GATHRIGHT, MICHAELChief Customer Officer
DisposalCommon equity
2270 sharesCommon Stock
$211.3KDirectional evidence
LUCANIA, JAMES MEVP & CFO
DisposalCommon equity
2839 sharesCommon Stock
$269.9KDirectional evidence
FIORE, MICHAEL HENRYEVP, CHIEF COMMERCIAL OFFICER
DisposalCommon equity
2045 sharesCommon Stock
$194.4KDirectional evidence
CUTLER, SCOTTDirector, President and CEO
DisposalCommon equity
1238 sharesCommon Stock
$117.7KDirectional evidence
NEELEMAN, STEPHENDirector, FOUNDER AND VICE CHAIRMAN
DisposalCommon equity
1103 sharesCommon Stock
$104.9KDirectional evidence
LADD, DELANOEVP, General Counsel
DisposalCommon equity
1087 sharesCommon Stock
$103.4KDirectional evidence
FIORE, MICHAEL HENRYEVP, CHIEF COMMERCIAL OFFICER
DisposalCommon equity
2470 sharesCommon Stock
$234.7KDirectional evidence
DILLON, ADRIAN TDirector
AcquisitionCommon equity
2877 sharesCommon Stock
Not reportedContext evidence
DILSAVER, EVELYN SDirector
AcquisitionCommon equity
2877 sharesCommon Stock
Not reportedContext evidence
GASSEN, WILLIAMDirector
AcquisitionCommon equity
2877 sharesCommon Stock
Not reportedContext evidence
MCCOWAN, DEBRA CHARLOTTEDirector
AcquisitionCommon equity
2877 sharesCommon Stock
Not reportedContext evidence
NATARAJAN, RAJESHDirector
AcquisitionCommon equity
2877 sharesCommon Stock
Not reportedContext evidence
PARKER, STUART B.Director
AcquisitionCommon equity
2877 sharesCommon Stock
Not reportedContext evidence
SELANDER, ROBERT WDirector
AcquisitionCommon equity
2877 sharesCommon Stock
Not reportedContext evidence
WELLBORN, GAYLE FURGURSONDirector
AcquisitionCommon equity
2877 sharesCommon Stock
Not reportedContext evidence
FIORE, MICHAEL HENRYEVP, CHIEF COMMERCIAL OFFICER
DisposalCommon equity
3142 sharesCommon Stock
$298.5KDirectional evidence
WELLBORN, GAYLE FURGURSONDirector
DisposalOptions and derivatives
2439 sharesStock Option (right to buy)
Not reportedContext evidence
LADD, DELANOEVP, General Counsel
DisposalCommon equity
7500 sharesCommon Stock
$675.0KDirectional evidence
WELLBORN, GAYLE FURGURSONDirector
DisposalCommon equity
2439 sharesCommon Stock
$219.5KDirectional evidence
WELLBORN, GAYLE FURGURSONDirector
AcquisitionCommon equity
2439 sharesCommon Stock
$115.1KDirectional evidence
CUTLER, SCOTTDirector, President and CEO
DisposalCommon equity
4931 sharesCommon Stock
$413.4KDirectional evidence
ROSNER, ELIMELECHEVP, CHIEF TECHNOLOGY OFFICER
DisposalCommon equity
4768 sharesCommon Stock
$399.7KDirectional evidence
LUCANIA, JAMES MEVP & CFO
DisposalCommon equity
4393 sharesCommon Stock
$368.3KDirectional evidence
FIORE, MICHAEL HENRYEVP, CHIEF COMMERCIAL OFFICER
DisposalCommon equity
3378 sharesCommon Stock
$283.2KDirectional evidence
NEELEMAN, STEPHENDirector, FOUNDER AND VICE CHAIRMAN
DisposalCommon equity
2559 sharesCommon Stock
$214.5KDirectional evidence
Reading the dossier
Direction and confidence are separate
Conviction
The 0 to 100 score classifies deduplicated priced common-share evidence. Fifty is balanced or non-directional.
Confidence
Confidence rises with controlled event depth, named-insider breadth, fresh evidence, normalized values, and a longer observation span.
Disposals
Selling is not treated as the mirror image of buying. It carries less directional weight because taxes, diversification, compensation, and planned transactions can all create sales.
Price confirmation
The market chart tests whether the filing thesis is being confirmed or rejected by price, fair-value position, relative strength, and the current trend state.
Independent market research for education. This classification is not investment advice, a recommendation, a forecast, or an execution instruction.